# Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy

> **NCT03332303** · PHASE3 · COMPLETED · sponsor: **Prasco LLC** · enrollment: 540 (actual)

## Conditions studied

- Vulvar and Vaginal Atrophy

## Interventions

- **DRUG:** Estrace® Cream
- **DRUG:** Estradiol Vaginal Cream
- **DRUG:** Vehicle Cream

## Key facts

- **NCT ID:** NCT03332303
- **Lead sponsor:** Prasco LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-26
- **Primary completion:** 2018-03-15
- **Final completion:** 2018-03-15
- **Target enrollment:** 540 (ACTUAL)
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03332303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03332303, "Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03332303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*